715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trialsVictor Cervera-Carrascon,Inge Svane,Katriina Peltola,Tuomo Alanko, Riitta Korpisaari,Susanna Juteau,Marjut Jaakkola,Jorma Sormunen,Juha Kononen, Eva Ellebaek Steensgaard,Tine Monberg,Marco Donia,Amir Khammari,Brigitte Dreno,Joao Santos,Suvi Sorsa,Riikka Havunen,Akseli HemminkiRegular and Young Investigator Award Abstracts（2022）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
